PACH

10.4200.00%
MR

Mitchell R. Creem

CEO & Director

Mr. Mitchell R. Creem, M.H.A., is Chief Financial Officer of Vesicor Therapeutics, Inc. from January 27, 2026. He is Chief Executive Officer and Director of Pioneer Acquisition I Corp. He served as Independent Director at Nutex Health, Inc. since April 1, 2022 until July 14, 2025. He also serves as Independent Director at Accountable Healthcare America Inc. since 2021. From October 2015 to July 2017, Mr. Creem served as the Chief Executive and Administrative Officer of Verity Health Systems of California, Inc. and certain of its subsidiaries (“Verity”)Verity Health System. Mr. Creem serves as President of The Bridgewater Healthcare Group. He served as a Director of Clinigence Holdings, Inc. from April 2019 to April 2022. Mr. Creem served as the Chief Executive Officer of USC Norris Cancer Hospital since April 2009. He served as Chief Executive Officer of Keck Hospital of USC (formerly USC University Hospital, Inc.) from April 2009 to July 02, 2012. Mr. Creem is currently a principal at GreenRock Capital. Mr. Creem served as the Chief Financial Officer and Principal Accounting Officer of Apollo Medical Holdings, Inc. from May 22, 2014 to September 2015. He joined University of Southern California (USC) as a Vice Provost in June 2008. Mr. Creem joined USC with experience in turning around academic medical centers and numerous achievements at the teaching hospitals of UCLA, Harvard University and Tufts University. He served as the Associate Vice Chancellor and Chief Financial Officer for the UCLA Medical Sciences, a group of institutions that includes the Geffen School of Medicine at UCLA, UCLA Faculty Practice and the UCLA Hospital System. Mr. Creem served briefly as Interim Chief Information Officer for UCLA Medical Sciences, where he developed the information technology strategy and transition plan for the new hospital buildings. He has extensive management experience covering all aspects of the health care industry, including hospital, research and faculty group practice management. Mr. Creem also has held several key administrative and financial positions at Massachusetts General Hospital in Boston, where he helped launch two for-profit subsidiaries in international telemedicine services and hardware/software sales. He served as Chief Financial Officer and Director of Apollo Medical Holdings, Inc. from October 22, 2012 to October 2015. Mr. Creem also worked for several years in a senior management position at the Healthcare Practice Group of PricewaterhouseCoopers, where he was responsible for numerous consulting engagements, financial statement audits and financial feasibility studies. In the hospital and health care sector, he has considerable experience with business valuation and pricing strategies; organizational, financial and governance structures; strategies for clinical and operational consolidation; bankruptcies and reorganizations; and health care start-ups. He has been a Guest Lecturer at USC, UCLA and Harvard University. He is a visiting professor at the UCLA School of Public Health. He served as Chief Financial Officer of Beth Israel Deaconess Medical Center, a Harvard University teaching hospital and Chief Financial Officer of Tufts University Medical Center. Mr. Creem earned a master’s degree in health administration from Duke University and a B.S. in Accounting and Business Administration from Boston University.

Positions